Shamik Sharma

Shamik Sharma's work experience includes roles in various biotechnology and pharmaceutical companies.

At Voyager Therapeutics, Inc., Shamik worked as the Director of Cell Culture Development since July 2021. In this role, they managed a team of scientists and led the optimization of cultivation and infection processes for AAV vectors. Shamik also coordinated upstream development activities, served as the CMC lead for portfolio programs, and established workflows to support regulatory strategy.

Before that, Shamik held the position of Associate Director of Cell Culture Development at Voyager Therapeutics from February 2020 to July 2021, where they contributed to the company's molecular biology and upstream process development efforts.

Prior to joining Voyager Therapeutics, Shamik worked at Pfizer from 2008 to 2019. Shamik held various roles, including Pharmaceutical Sciences Team Leader and Principal Scientist in the Bioprocess R&D Portfolio Group. In these positions, they led matrix teams, coordinated technology transfers, and developed regulatory filing strategies. Shamik also executed and supervised upstream process development for therapeutic proteins expressed in different organisms and led technology transfers to manufacturing facilities.

Earlier in their career, Shamik worked as a Process Engineer at New England Biolabs from 2005 to 2008. In this role, they established a fermentation laboratory and designed a production scale filtration system for protein expression optimization.

Overall, Shamik Sharma has extensive experience in cell culture development, process optimization, technology transfer, and regulatory strategy in the biotechnology and pharmaceutical industries.

Shamik Sharma's education history begins in 1996 when they attended Savitribai Phule Pune University. From 1996 to 2000, they pursued a Bachelor's degree in Chemical Engineering. Shamik then transferred to New Mexico State University in 2000, where they continued their studies in Chemical Engineering until 2002. At this point, they decided to further their education and enrolled in Clemson University from 2002 to 2005, where they obtained a Ph.D. in Chemical Engineering.